Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
4
×
life sciences
lung cancer
4
×
national blog main
national top stories
new york blog main
new york top stories
4
×
san francisco blog main
san francisco top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
johnson & johnson
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
deals
abbvie
abeona therapeutics
ac immune
achaogen
acquisition
affordable care act
alex gorsky
alliances
What
bio
health
medicine
roundup
took
acquiring
alzheimer’s
auris
billion
biopharma
builds
buy
cancer
car
cash
celgene
colleagues
company’s
congress
deal
democrats
developer
divided
drug
eisai
elections
exome
fallout
fda
flags
government
higher
hundreds
incidence
industry
johnson
lorcaserin
loss
losses
market
Language
unset
Current search:
fda
×
" new york top stories "
×
" lung cancer "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel